Cna Financial Corp Praxis Precision Medicines, Inc. Transaction History

Cna Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.75 - $11.34 $32,796 - $212,522	-18,741 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$10.21 - $20.29 $5,207 - $10,347	510 Added 2.8%	18,741 $191,000
Q4 2021 Feb 11, 2022	BUY	$16.76 - $22.99 $23,296 - $31,956	1,390 Added 8.25%	18,231 $359,000
Q3 2021 Nov 12, 2021	BUY	$13.15 - $22.56 $26,431 - $45,345	2,010 Added 13.55%	16,841 $311,000
Q2 2021 Aug 12, 2021	BUY	$18.28 - $33.05 $89,572 - $161,945	4,900 Added 49.34%	14,831 $271,000
Q1 2021 May 14, 2021	BUY	$29.34 - $60.2 $56,626 - $116,186	1,930 Added 24.12%	9,931 $325,000
Q4 2020 Feb 12, 2021	BUY	$27.25 - $55.82 $218,027 - $446,615	8,001 New	8,001 $440,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.